A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

Cytomegalovirus (CMV) infection is a common complication of allogeneic hematopoietic cell transplantation (HCT). In this trial, we randomized adult CMV-seropositive HCT recipients without CMV viremia at screening 2:1 to receive brincidofovir or placebo until week 14 post-HCT. Randomization was strat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biol Blood Marrow Transplant
Main Authors: Marty, Francisco M., Winston, Drew J., Chemaly, Roy F., Mullane, Kathleen M., Shore, Tsiporah B., Papanicolaou, Genovefa A., Chittick, Greg, Brundage, Thomas M., Wilson, Chad, Morrison, Marion E., Foster, Scott A., Nichols, W. Garrett, Boeckh, Michael J.
Format: Artigo
Jezik:Inglês
Izdano: 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8196624/
https://ncbi.nlm.nih.gov/pubmed/30292744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2018.09.038
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki